Sagimet Biosciences (SGMT) Cash & Current Investments (2022 - 2026)
Sagimet Biosciences (SGMT) posted Cash & Current Investments of $240.13 million for Q2 2026, up 91.5% from $125.41 million a year earlier and up 129.7% from the prior quarter.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Cash & Current Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Sagimet Biosciences' Cash & Current Investments came in at $113.12 million, down 25.2% from FY2024.
- Annual Cash & Current Investments shows a three-year compound annual growth rate of 51.7% (FY2022 to FY2025).
- In prior years, Sagimet Biosciences' Cash & Current Investments was $151.25 million in FY2024 (+59.4%), $94.9 million in FY2023 (+193.0%) and $32.39 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Cash & Current Investments in data going back to Q4 2022.
- On a year-over-year basis, Cash & Current Investments increased in three of the last eight quarters, with growth averaging 9.3%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q2 2024, with growth of 798.9%; the weakest was Q1 2026, with a decline of 27.7%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $104.54 million (Q1 2026), $113.12 million (Q4 2025) and $116.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.26 Bn | 1,101.85 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.92 Bn | 555.78 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 506.32 Bn | 479.44 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.38 Bn | 312.76 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 293.00 Bn | 256.99 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.76 Bn | 239.44 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.88 Bn | 193.27 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.26 Bn | 169.45 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.34 Bn | 117.99 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Sagimet Biosciences | 510.96 Mn | -63.52 Mn | - | 240.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.13 Mn |
| Mar 31, 2026 | 104.54 Mn |
| Dec 31, 2025 | 113.12 Mn |
| Sep 30, 2025 | 116.69 Mn |
| Jun 30, 2025 | 125.41 Mn |
| Mar 31, 2025 | 144.57 Mn |
| Dec 31, 2024 | 151.25 Mn |
| Sep 30, 2024 | 152.49 Mn |
| Jun 30, 2024 | 166.37 Mn |
| Mar 31, 2024 | 193.71 Mn |
| Dec 31, 2023 | 94.90 Mn |
| Sep 30, 2023 | 101.84 Mn |
| Jun 30, 2023 | 18.51 Mn |
| Dec 31, 2022 | 32.39 Mn |
API Access
Sagimet Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();